Prevalence of anemia and its correlation with clinical parameters in patients from a multidisciplinary heart failure unit;Anemia y parámetros relacionados en pacientes de una unidad de insuficiencia cardíaca multidisciplinaria

Medicina Clinica

Volumn 122, Issue 4, 2004, Pages 121-125

  Urrutia, Agustín ^a   Lupón, Josep ^a   González, Beatriz ^a   Parajón, Teresa ^a   Altimir, Salvador ^a   Coll, Ramon ^a   Prats, Montserrat ^a   Rey Joly, Celestino ^a   Valle, Vicente ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Anemia; Heart failure; Hemoglobin

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN; NITRATE; UREA;

ADULT; AGE; AGED; ANEMIA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; COMORBIDITY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIABETES MELLITUS; DISEASE CLASSIFICATION; DIURETIC THERAPY; FEMALE; GENDER; HEART FAILURE; HEMOGLOBIN DETERMINATION; HUMAN; INTENSIVE CARE UNIT; KRUSKAL WALLIS TEST; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIDISCIPLINARY HEART FAILURE UNIT; MULTIPLE REGRESSION; OUTCOMES RESEARCH; PREVALENCE; QUALITY OF LIFE; SEX DIFFERENCE; SMOKING HABIT; STATISTICAL ANALYSIS; STUDENT T TEST; UREA BLOOD LEVEL;

EID: 1642303877     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(04)74168-8     Document Type: Article

References (12)

1. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovich E, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduce hospitalisations. J Am Coll Cardiol 2000:35:1737-44.
2. Tanner H, Moschovitis G, Kuster GM, Hullin R, Pfiffner D, Hess OM, et al. The prevalence of anemia in chronic heart failure. Int J Cardiol 2002; 86:115-121.
3. Ezekowitz JA, McAlister FA, Amstrong PW. Anemia is common in heart failure and is associated with poor outcomes. Insights from a cohort of 12065 patients with new-onset heart failure. Circulation 2003;107:223-5.
4. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant incresae in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780-6.
5. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, et al. Hemodilution is common in patients with advanced heart failure. Circulation 2003;107:226-9.
6. Parsi A, Kleber FX. Anaemia in heart failure: its diagnosis and management. Eur J Heart Fail 2003;5:3-4.
7. Chatterjee B, Nydegger UE, Mohacsi P. Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT(1) antagonists. Eur J Hear Fail 2000;2:393-8.
8. Silveberg DS, Wexler D, Iaina A. The importance of anaemia and its correction in the management of severe congestive heart failure. Eur J Heart Failure 2002;4:681-6.
9. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis 1977;30 (Suppl): 193-240.
10. Levy D, Kenchaiah S, Larson M, Benjamin EJ, Kupka MJ, Ho KK, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397-402.
11. Silverberg DS, Wexler D, Sheps D, Blum M, Karen G, Baruch R, et al. The effect of correction of mild anaemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomised controlled study. J Am Coll Cardiol 2001;37: 1775-80.
12. Silveberg DS, Wexler D, Blum M, Tchebiner JZ, Sheps D, Keren G, et al. The effect of correction of anemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant 2003;18:141-6.